Moleculin Biotech
MBRX
MBRX
29 hedge funds and large institutions have $3.71M invested in Moleculin Biotech in 2020 Q2 according to their latest regulatory filings, with 13 funds opening new positions, 5 increasing their positions, 3 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
0.03% less ownership
Funds ownership: 0.1% → 0.07% (-0.03%)
Holders
29
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$100K | |
| 2 | +$97.1K | |
| 3 | +$75.1K | |
| 4 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
+$62K |
| 5 |
Bank of America
Charlotte,
North Carolina
|
+$39K |
Top Sellers
| 1 | -$1.07M | |
| 2 | -$92.6K | |
| 3 | -$55K | |
| 4 |
RJFSA
Raymond James Financial Services Advisors
St. Petersburg,
Florida
|
-$44K |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$22K |